Charles Schwab’s CASTLIGHT HEALTH, INC. CSLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-316,569
Closed -$488K 3670
2021
Q4
$488K Buy
316,569
+18,933
+6% +$31.2K ﹤0.01% 3151
2021
Q3
$468K Sell
297,636
-408,562
-58% -$800K ﹤0.01% 3170
2021
Q2
$1.86M Buy
706,198
+259,277
+58% +$483K ﹤0.01% 2741
2021
Q1
$675K Buy
446,921
+43,840
+11% +$76K ﹤0.01% 2981
2020
Q4
$525K Buy
403,081
+9,156
+2% +$10.3K ﹤0.01% 2977
2020
Q3
$446K Buy
393,925
+56,956
+17% +$62.6K ﹤0.01% 2903
2020
Q2
$280K Sell
336,969
-179,686
-35% -$133K ﹤0.01% 3073
2020
Q1
$374K Buy
516,655
+9,406
+2% +$10.5K ﹤0.01% 2808
2019
Q4
$675K Buy
507,249
+5,582
+1% +$7.79K ﹤0.01% 2718
2019
Q3
$708K Buy
501,667
+23,399
+5% +$46.6K ﹤0.01% 2669
2019
Q2
$1.54M Buy
478,268
+53,485
+13% +$184K ﹤0.01% 2445
2019
Q1
$1.59M Buy
424,783
+4,937
+1% +$15.7K ﹤0.01% 2426
2018
Q4
$912K Buy
419,846
+11,098
+3% +$27.5K ﹤0.01% 2563
2018
Q3
$1.1M Buy
408,748
+43,158
+12% +$152K ﹤0.01% 2589
2018
Q2
$1.55M Buy
365,590
+94,310
+35% +$354K ﹤0.01% 2447
2018
Q1
$991K Buy
271,280
+9,009
+3% +$33.4K ﹤0.01% 2516
2017
Q4
$984K Buy
262,271
+212
+0.1% +$849 ﹤0.01% 2510
2017
Q3
$1.13M Buy
262,059
+12,778
+5% +$52.6K ﹤0.01% 2475
2017
Q2
$1.03M Buy
249,281
+50,687
+26% +$198K ﹤0.01% 2446
2017
Q1
$725K Buy
198,594
+12,483
+7% +$43.8K ﹤0.01% 2528
2016
Q4
$922K Buy
186,111
+55,003
+42% +$249K ﹤0.01% 2457
2016
Q3
$546K Buy
131,108
+36,014
+38% +$147K ﹤0.01% 2583
2016
Q2
$377K Buy
95,094
+1,638
+2% +$6.42K ﹤0.01% 2699
2016
Q1
$312K Buy
93,456
+1,989
+2% +$6.54K ﹤0.01% 2759
2015
Q4
$391K Buy
91,467
+2,535
+3% +$10.9K ﹤0.01% 2752
2015
Q3
$374K Buy
88,932
+30,376
+52% +$192K ﹤0.01% 2738
2015
Q2
$477K Buy
58,556
+27,657
+90% +$230K ﹤0.01% 2689
2015
Q1
$240K Buy
30,899
+1,392
+5% +$11.9K ﹤0.01% 2909
2014
Q4
$346K Buy
29,507
+732
+3% +$8.74K ﹤0.01% 2788
2014
Q3
$373K Buy
28,775
+612
+2% +$8.07K ﹤0.01% 2699
2014
Q2
$429K Buy
+28,163
New +$458K ﹤0.01% 2692

Charles Schwab's CSLT Position: Q1 2022 in Review

Charles Schwab sold out of CASTLIGHT HEALTH, INC. (CSLT) in Q1 2022, closing a stake of 316,569 shares — an estimated $488K sold.

Charles Schwab first reported a position in CSLT in Q2 2014 and held it in 31 quarters. The position peaked at $1.86M in Q2 2021. 0 funds tracked by Wall St. Rank hold CSLT as of Q1 2022.

  • Charles Schwab reported no remaining CASTLIGHT HEALTH, INC. position as of Q1 2022 after selling out during the quarter.
  • Charles Schwab sold 316,569 CASTLIGHT HEALTH, INC. shares in Q1 2022, an estimated $488K.
  • Charles Schwab first reported a position in CASTLIGHT HEALTH, INC. in Q2 2014 and held it in 31 quarters.
  • Charles Schwab's CASTLIGHT HEALTH, INC. position peaked at $1.86M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held CASTLIGHT HEALTH, INC. as of Q1 2022.

Based on Charles Schwab's 13F filing for Q1 2022, filed 13 May 2022.